Key regions: Australia, Brazil, United Kingdom, Europe, Canada
Madagascar, an island country located off the coast of Southeast Africa, has been experiencing a steady growth in the Other Vaccines market in recent years.
Customer preferences: Madagascar has a relatively young population, with a median age of 19 years, and a high birth rate, resulting in a growing demand for vaccines, including Other Vaccines. The country also faces various health challenges, such as a high prevalence of infectious diseases, which makes vaccination a crucial aspect of public health.
Trends in the market: The Other Vaccines market in Madagascar has been growing due to the increasing demand for vaccines to prevent infectious diseases such as meningococcal disease, pneumococcal disease, and rotavirus. The government has been actively promoting vaccination programs, which has led to an increase in vaccine coverage, particularly among children. Additionally, there has been a rise in private healthcare facilities, which has contributed to the growth of the Other Vaccines market in the country.
Local special circumstances: Madagascar is a low-income country, and the cost of vaccines can be a significant barrier to access. However, the government has been working to address this issue by providing free vaccines to children under the age of one, as well as subsidizing the cost of other vaccines. The country also faces challenges in terms of vaccine distribution due to its geography, as many areas are remote and difficult to access.
Underlying macroeconomic factors: Madagascar has experienced economic growth in recent years, with a focus on developing the healthcare sector. The government has been investing in healthcare infrastructure and increasing the number of healthcare workers in the country. However, the country still faces challenges such as political instability, which can impact the healthcare system. The COVID-19 pandemic has also had an impact on the Other Vaccines market in Madagascar, with disruptions to vaccine supply chains and a shift in focus towards COVID-19 vaccination efforts. In conclusion, the Other Vaccines market in Madagascar has been growing due to increasing demand for vaccines to prevent infectious diseases, government promotion of vaccination programs, and the rise of private healthcare facilities. The country still faces challenges in terms of vaccine access and distribution due to its low-income status and geography. However, the government's investment in healthcare infrastructure and the country's economic growth provide opportunities for further development of the Other Vaccines market in Madagascar.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
